Skip to content

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%
IQVIA logo
IQVIAIQV
$42.75B-2.5%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$10B+71.5%
Veeva Systems logo
Veeva SystemsVEEV
$23.68B-32.6%
Medline, Inc.
 logo
Medline, Inc. MDLN
$46.44B

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s enterprise value?
Medpace Holdings, Inc. (MEDP) reported enterprise value of $13.12B in Q1 2026.
How has Medpace Holdings, Inc.'s enterprise value changed year-over-year?
Medpace Holdings, Inc.'s enterprise value increased by 45.9% year-over-year, from $8.99B to $13.12B.
What is the long-term trend for Medpace Holdings, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s enterprise value has grown at a 26.1% compound annual growth rate (CAGR), from $4.86B to $15.46B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.